COVID-19: epidemiological update. Weekly report. Week 51. 30 December 2021.
Key points
In week 51, the circulation of SARS-CoV-2 surged with strong growth in Omicron, which is now the dominant variant.
Metropolitan France:
Incidence rate* above 1,000/100,000 inhabitants in Île-de-France, Provence-Alpes-Côte d’Azur, Corsica, and Auvergne-Rhône-Alpes
Largest increase in the incidence rate* among 20-29 and 30-39 year-olds
New hospital and intensive care admissions stable but high at the national level with regional disparities
Overseas France:
Sharp rise in the incidence rate* in Guadeloupe and Mayotte
Incidence rate still very high in Reunion Island
Variants
62.4% of screened tests showing a profile compatible with the Omicron variant at the start of week 52
Omicron representing 15% of interpretable sequences in the Flash Survey from week 50 (13 December)
Prevention
Vaccination on 28 December 2021 (Vaccin Covid data):
77,0% of the French population had received a complete primary vaccination series
43.7% of the 18+ age group (80.7% of eligible people) and 70.6% of the 65+ age group (87.9% of eligible people) had received a booster shot
Importance of combining different measures: complete vaccination schedule (including complete primary vaccination and booster shot after 3 months) as well as adherence to contact tracing and recommended guidelines
Compliance with preventive measures, including reducing contacts and frequently ventilating enclosed spaces, is essential during the end-of-year festive period given the circulation of the Omicron variant
En relation avec
Nos dernières actualités
actualité
Se baigner en toute sécurité en adoptant les bons gestes
actualité
Santé publique France publie son Rapport annuel 2025 : 10 ans d’engagement...
actualité